Clinical Trials Directory

Trials / Completed

CompletedNCT04924842

COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA - Nosocor Phase 2)

Epidemiology of CoV-2 SARS Infections: Dynamics of Community Contamination in Children and Adults - Impact of Variants

Status
Completed
Phase
Study type
Observational
Enrollment
87 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Unlike other respiratory viruses such as influenza and RSV where the child is the essential reservoir and central vector of intrafamilial contamination, the child is likely to be a small player in the transmission of CoV2-CoRSA infection. This study aims to describe the age category of the first contact, within 14 days before the appearance of the first symptoms of the index case in order to describe the age categories of this first contaminant, globally, in the group of children and finally in the group of adults. This work is intended to provide food for discussion and to justify the distancing and containment measures imposed on children when their isolation has a deleterious impact that has now been established for some children.

Conditions

Interventions

TypeNameDescription
OTHERReview of medical fileReview of medical patient file, including patient tracing, brief summary of the disease course, barrier gestures, social distancing.
OTHERPhone call interviewless than 15 minutes phone call

Timeline

Start date
2021-06-22
Primary completion
2021-10-28
Completion
2021-10-28
First posted
2021-06-14
Last updated
2022-01-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04924842. Inclusion in this directory is not an endorsement.